« Back
Home /
JMJD2D Peptide - C-terminal region (AAP39325)

JMJD2D Peptide - C-terminal region (AAP39325)

Item no.	AAP39325
Manufacturer	AVIVA Systems Biology
Amount	100 ug
Category	Oncology By Cell Type Carcinoma Hematology Leukemia Peptides & Proteins Immunohistochemistry Western Blot Peptides
Type	Peptides
Format	Lyophilized powder
Applications	WB, IHC
Specific against	other
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	FLJ10251
Similar products	JMJD2D
Available
Description	This is a synthetic peptide designed for use in combination with anti-JMJD2D antibody (Catalog #: ARP39325_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Gene symbol	KDM4D
Protein size	523
Molecular weight	59kDa
Product format	Lyophilized powder
Gene id	55693
Reconstitution and storage	Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles.
Partner proteins	HECW2. PPP1CC. CUL4B. TP53. AR. KDM4D.
Description of target	JMJD2D belongs to JMJD2 family that is consist of four cancer-associated genes

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

AAP39325-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 100 ug

available

Delivery expected until 9/11/2025

Express Delivery: Save 9 days

Compare

Add to wishlist

Get an offer